BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
BRUKER CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$55.37+0.57 (+1.04%)
Close on Oct 19, 2026
- Market cap
- $8.43B
- P/E (TTM)
- –
- Dividend yield
- –
Bruker statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Laboratory Analytical Instruments companies for comparison
Valuation
| Measure | Bruker | Industry median |
|---|---|---|
| Market Cap | $8.59B | $230.55M |
| Enterprise Value | $10.23B | $202.97M |
| PS Ratio | 2.45 | 3.11 |
| P/FCF Ratio | 91.47 | 27.25 |
| P/OCF Ratio | 45.11 | 22.35 |
Enterprise value
| Measure | Bruker | Industry median |
|---|---|---|
| EV / Sales | 2.92 | 2.92 |
| EV / EBITDA | 51.27 | 19.86 |
| EV / FCF | 108.93 | 27.85 |
Income (trailing twelve months)
| Measure | Bruker | Industry median |
|---|---|---|
| Revenue | $3.50B | $102.39M |
| Gross Profit | $1.62B | $60.36M |
| Operating Income | -$30.60M | -$4.31M |
| Pretax Income | -$22.40M | -$2.26M |
| Net Income | -$71.20M | -$6.57M |
| EBITDA | $199.50M | -$1.98M |
| EPS (Diluted) | -$0.70 | -$0.07 |
Margins
| Measure | Bruker | Industry median |
|---|---|---|
| Gross Margin | 46.4% | 55.1% |
| Operating Margin | -0.87% | -6.04% |
| Pretax Margin | -0.64% | -4.11% |
| Profit Margin | -2.03% | -10.5% |
| EBITDA Margin | 5.70% | -2.67% |
| FCF Margin | 2.68% | -0.30% |
Returns
| Measure | Bruker | Industry median |
|---|---|---|
| Return on Assets (ROA) | -1.15% | -13.3% |
| Return on Capital Employed (ROCE) | -0.63% | -9.07% |
Growth
| Measure | Bruker | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 1.65% | 8.85% |
| Net Income Growth (YoY) | -189.4% | 10.6% |
| EPS Growth (YoY) | -234.6% | 10.6% |
| FCF Growth (YoY) | 90.5% | 10.6% |
| Revenue Growth (3Y CAGR) | 10.7% | 7.08% |
| Revenue Growth (5Y CAGR) | 11.6% | 11.8% |
Balance sheet
| Measure | Bruker | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $184.90M | $37.33M |
| Total Debt | $1.82B | $72.66M |
| Net Cash (Debt) | -$1.64B | $3.92M |
| Net Cash Per Share | -$10.57 | $0.28 |
| Working Capital | $1.02B | $54.64M |
Financial position
| Measure | Bruker | Industry median |
|---|---|---|
| Current Ratio | 1.85 | 2.50 |
| Quick Ratio | 0.61 | 1.54 |
| Debt / EBITDA | 9.15 | 2.31 |
| Debt / FCF | 19.43 | 3.50 |
| Net Debt / EBITDA | 8.22 | 1.53 |
| Interest Coverage | -0.50 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Bruker | Industry median |
|---|---|---|
| Operating Cash Flow | $190.40M | -$653.46K |
| Capital Expenditures | -$96.50M | -$3.69M |
| Free Cash Flow | $93.90M | -$835.02K |
| FCF Per Share | $0.61 | -$0.02 |
Efficiency
| Measure | Bruker | Industry median |
|---|---|---|
| Asset Turnover | 0.56 | 0.59 |
| Inventory Turnover | 1.60 | 2.21 |
| Revenue Per Employee | $315.71K | $322.57K |
| Profits Per Employee | -$6.42K | -$51.88K |
| Employee Count | 11,085 | 185 |
Dividends and yields
| Measure | Bruker | Industry median |
|---|---|---|
| Earnings Yield | -0.83% | -6.91% |
| FCF Yield | 1.09% | -0.56% |
| FCF Payout Ratio | 24.1% | 21.9% |
Shares
| Measure | Bruker | Industry median |
|---|---|---|
| Shares Outstanding | 155,119,000 | 44,856,700 |
| Shares Change (YoY) | 0.23% | 3.35% |
| Shares Change (QoQ) | 0.09% | 0.27% |
| Float | 114,146,000 | 37,097,900 |
| Shares Held by Insiders | 26.4% | 10.6% |
| Shares Held by Institutions | 91.4% | 63.5% |
Taxes
| Measure | Bruker | Industry median |
|---|---|---|
| Income Tax | $40.40M | $1.52M |
Scores
| Measure | Bruker | Industry median |
|---|---|---|
| Altman Z-Score | 2.17 | 1.95 |
| Piotroski F-Score | 4 | 5 |
| Beneish M-Score | -2.56 | -2.64 |
Calculated by StockData from Bruker's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.